-
Mashup Score: 0
Increases in oxidized HDL levels were linked to HFpEF in new analyses, suggesting reduced antioxidant HDL function is present in this patient population.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6
Submission of the supplemental NDA was based on positive findings from the FINEARTS-HF trial investigating finerenone for heart failure with an LVEF ≥40%.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Potassium nitrate increased blood nitric oxide metabolites but showed no improvement in exercise tolerance or quality of life in a population with HFpEF.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Empagliflozin Misses Primary Endpoint in Post-MI Patient Population, EMPACT-MI Trial - 10 month(s) ago
Results of EMPACT-MI suggest use of empagliflozin was not associated with a statistically significant reduction in a composite of death and heart failure hospitalization.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
Participation in the Bundled Payments for Care Improvement Model 2 Heart Failure program did not improve all-cause mortality or readmission rates.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
Elevated levels of oxidized HDL were associated with heart failure with preserved ejection fraction in a new analysis, pointing to a reduced HDL antioxidant function in this population. 🔗https://t.co/8byrTirPhC #HeartFailure #Cardiology